Logo image of ZAL.OL

ZALARIS ASA (ZAL.OL) Stock Fundamental Analysis

Europe - Euronext Oslo - OSL:ZAL - NO0010708910 - Common Stock

88.4 NOK
-1.6 (-1.78%)
Last: 11/28/2025, 4:17:51 PM
Fundamental Rating

5

Taking everything into account, ZAL scores 5 out of 10 in our fundamental rating. ZAL was compared to 31 industry peers in the Professional Services industry. ZAL has an average financial health and profitability rating. ZAL has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

ZAL had positive earnings in the past year.
In the past year ZAL had a positive cash flow from operations.
In multiple years ZAL reported negative net income over the last 5 years.
In the past 5 years ZAL always reported a positive cash flow from operatings.
ZAL.OL Yearly Net Income VS EBIT VS OCF VS FCFZAL.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M

1.2 Ratios

With a decent Return On Assets value of 5.60%, ZAL is doing good in the industry, outperforming 67.74% of the companies in the same industry.
With a decent Return On Equity value of 27.88%, ZAL is doing good in the industry, outperforming 77.42% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 13.39%, ZAL is in the better half of the industry, outperforming 77.42% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for ZAL is below the industry average of 10.37%.
The last Return On Invested Capital (13.39%) for ZAL is above the 3 year average (7.14%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 5.6%
ROE 27.88%
ROIC 13.39%
ROA(3y)-0.58%
ROA(5y)-0.28%
ROE(3y)-3.56%
ROE(5y)-2.63%
ROIC(3y)7.14%
ROIC(5y)5.76%
ZAL.OL Yearly ROA, ROE, ROICZAL.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20

1.3 Margins

ZAL's Profit Margin of 5.12% is fine compared to the rest of the industry. ZAL outperforms 67.74% of its industry peers.
In the last couple of years the Profit Margin of ZAL has grown nicely.
ZAL's Operating Margin of 10.60% is fine compared to the rest of the industry. ZAL outperforms 74.19% of its industry peers.
ZAL's Operating Margin has improved in the last couple of years.
Industry RankSector Rank
OM 10.6%
PM (TTM) 5.12%
GM N/A
OM growth 3Y38.03%
OM growth 5Y33.39%
PM growth 3Y14.91%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ZAL.OL Yearly Profit, Operating, Gross MarginsZAL.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 -2 4 -4 6 8

6

2. Health

2.1 Basic Checks

ZAL has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
ZAL has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for ZAL has been increased compared to 5 years ago.
Compared to 1 year ago, ZAL has an improved debt to assets ratio.
ZAL.OL Yearly Shares OutstandingZAL.OL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
ZAL.OL Yearly Total Debt VS Total AssetsZAL.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

ZAL has an Altman-Z score of 3.02. This indicates that ZAL is financially healthy and has little risk of bankruptcy at the moment.
ZAL has a Altman-Z score of 3.02. This is in the better half of the industry: ZAL outperforms 70.97% of its industry peers.
The Debt to FCF ratio of ZAL is 3.88, which is a good value as it means it would take ZAL, 3.88 years of fcf income to pay off all of its debts.
ZAL has a Debt to FCF ratio of 3.88. This is in the better half of the industry: ZAL outperforms 67.74% of its industry peers.
ZAL has a Debt/Equity ratio of 1.86. This is a high value indicating a heavy dependency on external financing.
ZAL's Debt to Equity ratio of 1.86 is on the low side compared to the rest of the industry. ZAL is outperformed by 67.74% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.86
Debt/FCF 3.88
Altman-Z 3.02
ROIC/WACC1.68
WACC7.96%
ZAL.OL Yearly LT Debt VS Equity VS FCFZAL.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

2.3 Liquidity

ZAL has a Current Ratio of 1.64. This is a normal value and indicates that ZAL is financially healthy and should not expect problems in meeting its short term obligations.
ZAL's Current ratio of 1.64 is amongst the best of the industry. ZAL outperforms 83.87% of its industry peers.
ZAL has a Quick Ratio of 1.64. This is a normal value and indicates that ZAL is financially healthy and should not expect problems in meeting its short term obligations.
With an excellent Quick ratio value of 1.64, ZAL belongs to the best of the industry, outperforming 87.10% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.64
Quick Ratio 1.64
ZAL.OL Yearly Current Assets VS Current LiabilitesZAL.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

6

3. Growth

3.1 Past

ZAL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 64.71%, which is quite impressive.
The Earnings Per Share has been growing by 35.55% on average over the past years. This is a very strong growth
The Revenue has decreased by -8.73% in the past year.
The Revenue has been growing by 11.63% on average over the past years. This is quite good.
EPS 1Y (TTM)64.71%
EPS 3Y35.55%
EPS 5YN/A
EPS Q2Q%150%
Revenue 1Y (TTM)-8.73%
Revenue growth 3Y20.2%
Revenue growth 5Y11.63%
Sales Q2Q%10.32%

3.2 Future

The Earnings Per Share is expected to grow by 14.99% on average over the next years. This is quite good.
The Revenue is expected to grow by 9.40% on average over the next years. This is quite good.
EPS Next Y4.2%
EPS Next 2Y18.02%
EPS Next 3Y14.99%
EPS Next 5YN/A
Revenue Next Year12.6%
Revenue Next 2Y10.39%
Revenue Next 3Y9.4%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
ZAL.OL Yearly Revenue VS EstimatesZAL.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
ZAL.OL Yearly EPS VS EstimatesZAL.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 4 6

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 26.31, ZAL can be considered very expensive at the moment.
ZAL's Price/Earnings ratio is in line with the industry average.
ZAL's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 26.15.
With a Price/Forward Earnings ratio of 12.77, ZAL is valued correctly.
Based on the Price/Forward Earnings ratio, ZAL is valued a bit cheaper than 67.74% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.12, ZAL is valued rather cheaply.
Industry RankSector Rank
PE 26.31
Fwd PE 12.77
ZAL.OL Price Earnings VS Forward Price EarningsZAL.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ZAL is on the same level as its industry peers.
Based on the Price/Free Cash Flow ratio, ZAL is valued a bit cheaper than 64.52% of the companies in the same industry.
Industry RankSector Rank
P/FCF 14.35
EV/EBITDA 11.32
ZAL.OL Per share dataZAL.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ZAL does not grow enough to justify the current Price/Earnings ratio.
ZAL has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as ZAL's earnings are expected to grow with 14.99% in the coming years.
PEG (NY)6.26
PEG (5Y)N/A
EPS Next 2Y18.02%
EPS Next 3Y14.99%

1

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.07%, ZAL has a reasonable but not impressive dividend return.
ZAL's Dividend Yield is slightly below the industry average, which is at 3.20.
Compared to an average S&P500 Dividend Yield of 2.41, ZAL's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.07%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

DPN/A
EPS Next 2Y18.02%
EPS Next 3Y14.99%
ZAL.OL Yearly Income VS Free CF VS DividendZAL.OL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M

ZALARIS ASA

OSL:ZAL (11/28/2025, 4:17:51 PM)

88.4

-1.6 (-1.78%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)10-24 2025-10-24/bmo
Earnings (Next)02-26 2026-02-26
Inst Owners44.22%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.96B
Revenue(TTM)1.47B
Net Income(TTM)75.29M
Analysts80
Price Target109.65 (24.04%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.07%
Yearly Dividend0
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-15.74%
Min EPS beat(2)-24.39%
Max EPS beat(2)-7.08%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.71%
Min Revenue beat(2)-1.98%
Max Revenue beat(2)0.55%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)7.5%
PT rev (3m)7.5%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)2.67%
EPS NY rev (3m)0.98%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.4%
Revenue NY rev (3m)-0.13%
Valuation
Industry RankSector Rank
PE 26.31
Fwd PE 12.77
P/S 1.33
P/FCF 14.35
P/OCF 12.93
P/B 7.22
P/tB N/A
EV/EBITDA 11.32
EPS(TTM)3.36
EY3.8%
EPS(NY)6.92
Fwd EY7.83%
FCF(TTM)6.16
FCFY6.97%
OCF(TTM)6.84
OCFY7.74%
SpS66.47
BVpS12.24
TBVpS-2.21
PEG (NY)6.26
PEG (5Y)N/A
Graham Number30.42
Profitability
Industry RankSector Rank
ROA 5.6%
ROE 27.88%
ROCE 19.79%
ROIC 13.39%
ROICexc 13.39%
ROICexgc 22.54%
OM 10.6%
PM (TTM) 5.12%
GM N/A
FCFM 9.27%
ROA(3y)-0.58%
ROA(5y)-0.28%
ROE(3y)-3.56%
ROE(5y)-2.63%
ROIC(3y)7.14%
ROIC(5y)5.76%
ROICexc(3y)17.04%
ROICexc(5y)13.22%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)10.55%
ROCE(5y)8.52%
ROICexgc growth 3YN/A
ROICexgc growth 5Y18%
ROICexc growth 3Y28.82%
ROICexc growth 5Y35.65%
OM growth 3Y38.03%
OM growth 5Y33.39%
PM growth 3Y14.91%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover1.09
Health
Industry RankSector Rank
Debt/Equity 1.86
Debt/FCF 3.88
Debt/EBITDA 2.25
Cap/Depr 22.46%
Cap/Sales 1.02%
Interest Coverage 4.19
Cash Conversion 67.96%
Profit Quality 181.18%
Current Ratio 1.64
Quick Ratio 1.64
Altman-Z 3.02
F-Score8
WACC7.96%
ROIC/WACC1.68
Cap/Depr(3y)52.11%
Cap/Depr(5y)45.36%
Cap/Sales(3y)2.71%
Cap/Sales(5y)2.52%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)64.71%
EPS 3Y35.55%
EPS 5YN/A
EPS Q2Q%150%
EPS Next Y4.2%
EPS Next 2Y18.02%
EPS Next 3Y14.99%
EPS Next 5YN/A
Revenue 1Y (TTM)-8.73%
Revenue growth 3Y20.2%
Revenue growth 5Y11.63%
Sales Q2Q%10.32%
Revenue Next Year12.6%
Revenue Next 2Y10.39%
Revenue Next 3Y9.4%
Revenue Next 5YN/A
EBIT growth 1Y36.19%
EBIT growth 3Y65.91%
EBIT growth 5Y48.9%
EBIT Next Year96.03%
EBIT Next 3Y35.29%
EBIT Next 5YN/A
FCF growth 1Y830.81%
FCF growth 3Y103.15%
FCF growth 5Y43.58%
OCF growth 1Y464.1%
OCF growth 3Y58.47%
OCF growth 5Y25.33%

ZALARIS ASA / ZAL.OL FAQ

Can you provide the ChartMill fundamental rating for ZALARIS ASA?

ChartMill assigns a fundamental rating of 5 / 10 to ZAL.OL.


What is the valuation status of ZALARIS ASA (ZAL.OL) stock?

ChartMill assigns a valuation rating of 4 / 10 to ZALARIS ASA (ZAL.OL). This can be considered as Fairly Valued.


Can you provide the profitability details for ZALARIS ASA?

ZALARIS ASA (ZAL.OL) has a profitability rating of 6 / 10.


What is the expected EPS growth for ZALARIS ASA (ZAL.OL) stock?

The Earnings per Share (EPS) of ZALARIS ASA (ZAL.OL) is expected to grow by 4.2% in the next year.